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[626 words] 
 Reversal of type 2 diabetes in the context of bariatric surgery is currently of great interest. 
Discussion of the rapid and dramatic effects of bariatric surgery upon the pathophysiology of 
type 2 diabetes has concentrated almost exclusively on surgically induced change in the 
incretin hormones (1,2).  Little consideration has been given to reversal of type 2 diabetes by 
the effects of caloric restriction alone. We report a person with type 2 diabetes who returned 
to normal fasting blood glucose and HbA1c after reading a notice of grant award in Balance 
concerning effects of hypocaloric diet on glucose control.  
 
A 46 year old woman was found to have diabetes on routine screening (OGTT January 2009: 
8.1mmol/l fasting; 14.4mmol/l 2 hours). At the time of diagnosis HbA1c was 6.9% and weight 
was 120.2kg, with body mass index of 42.6kg/m2. On diagnosis of diabetes she joined 
Diabetes UK and read in Balance of a grant award for research on the mechanism of 
hypocaloric reversal of diabetes. She enquired about being a subject, but NHS ethics, NHS 
R&D, PCT R&D and Caldicott permissions had yet to be granted. She asked to participate in 
due course but set about losing weight. She attended weekly meetings of Overeaters 
Anonymous Great Britain for support. By the time the research permissions had been 
obtained 8 months later, weight had fallen to 108.9kg with fasting blood glucose of 4.8mM 
and HbA1c 5.9%.  
 
Motivation to bring about sustained weight loss was provided by the information that this 
would result in normalisation of blood glucose control.  Although this may not appear 
remarkable to many diabetologists who have observed similar effects of weight loss in 
individual cases, this has rarely been described in the literature.  The phenomenon was first 
described by Claude Bouchardet who observed that glucose disappeared from his patients 
urine during food shortage of the siege of Paris in 1870 (3).  More recently, dietary therapy 
alone was reported to achieve normal glucose tolerance in 20% of people with type 2 diabetes 
(4). The key to response lies in compliance, and the longer term difficulty lies in sustaining 
the negative calorie balance.  
 
Close examination of the hypotheses based upon unique changes of incretins following 
bariatric surgery suggests inconsistencies.  The “hindgut hypothesis” postulates that 
expedited delivery of nutrients to the distal small intestine enhances GLP1 secretion possibly 
with other incretins.  However, the absolute increase in GLP1 secretion reported is small (5) 
and not observed in type 2 diabetes (6). High dose replacement by GLP1 agonists bring about 
only modest improvement in glucose control (7).  The “foregut hypothesis” postulates that 
reversal due to exclusion of the duodenum and proximal duodenum from exposure to 
nutrients (2).  This has been postulated to decrease postprandial GIP and decrease glucagon 
secretion (1).  However, not all studies show GIP to be decreased and some show increased 
secretion in the weeks after gastric bypass (5,8).   
 
Whereas the incretin hormones achieve fine regulation, substrate supply drives metabolism. 
The basic metabolic fact has been overlooked that the restriction of calorie intake which 
necessarily follows bariatric surgery will bring about rapid decrease in the fatty liver typical 
of type 2 diabetes.  The degree of restriction relates to the extent of the surgical procedure. 
Even moderate dietary restriction has been shown to be associated with profound change in 
hepatic insulin sensitivity and marked fall in hepatic glucose output early during a 
hypocaloric diet (9). The associated time course of decrease in liver volume is over days (10). 
Conversely, the period before onset of type 2 diabetes is characterized by accumulation of 
liver fat (11).  
 
The observation of reversal of type 2 diabetes, by diet rather than by surgery, is most 
important.  This should inform advice given to people with type 2 diabetes at the time of 
diagnosis.   
 
 
 
 
References 
 
1. Knop FK. Resolution of type 2 diabetes following gastric bypass surgery: 
involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 
2009;52:2270-2276. 
2. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, 
Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery 
reveals a role of the proximal small intestine in the pathophysiology of type 2 
diabetes. Annals of surgery 2006;244(5):741-749. 
3. Bouchardat C. De la Glycosurie ou Diabète Sucré Paris: Baillière; 1875. 
4. Wales JK. Treatment of type 2 (non-insulin-dependent) diabetic patients with diet 
alone. Diabetologia 1982;23(3):240-245. 
5. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Olivan B. 
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric 
bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007;30(7):1709-
1716. 
6. Morinigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J. GLP-1 and 
changes in glucose tolerance following gastric bypass surgery in morbidly obese 
subjects. Obes Surg 2006;16(12):1594-1601. 
7. Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, 
Blonde L. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 
26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 
2009;374(9683):39-47. 
8. Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa 
B, Koshy N, Lee H, Yapp K, Olivan B. Effect of weight loss by gastric bypass 
surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 
diabetes. J Clin Endocrinol Metab 2008;93(7):2479-2485. 
9. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of 
nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by 
moderate weight reduction in patients with type 2 diabetes. Diabetes 2005;54(3):603-
608. 
10. Hollingsworth KG, Abubacker MZ, Joubert I, Allison ME, Lomas DJ. Low-
carbohydrate diet induced reduction of hepatic lipid content observed with a rapid 
non-invasive MRI technique. The British journal of radiology 2006;79(945):712-715. 
11. Taylor R. Pathogenesis of Type 2 diabetes: Tracing the reverse route from cure to 
cause. Diabetologia 2008;51:1781-1789. 
 
 
The subject of this case report has given written consent to publication.  
 
 
 
 
Dr Sarah Steven 
Newcastle Diabetes Centre, 
Newcastle General Hospital, 
Westgate Road,  
Newcastle-upon-Tyne 
NE4 6BE 
 
Dr Ee Lin Lim 
Magnetic Resonance Centre, 
Campus for Ageing and Vitality, 
Newcastle upon Tyne 
NE4 5PL 
Correspondence: 
 
Prof Roy Taylor 
Magnetic Resonance Centre, 
Campus for Ageing and Vitality, 
Newcastle upon Tyne 
NE4 5PL 
Email for correspondence: roy.taylor@ncl.ac.uk 
